We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ThromboGenics Licenses Innovative Technology from Eleven Biotherapeutics

News   Jul 05, 2013

 
ThromboGenics Licenses Innovative Technology from Eleven Biotherapeutics
 
 
 

RELATED ARTICLES

First Practice Guidelines for Clinical Evaluation of Alzheimer's disease

News

Alzheimer’s disease experts gather in Chicago to plan guidelines for clinicians

READ MORE

Broadly Acting Antibodies Found in Blood of Ebola Survivors

News

Scientists have discovered a set of powerful, broadly neutralizing antibodies in the blood of Ebola survivors. In animal studies, two of these antibodies provided substantial protection against disease caused by the three species known to cause fatal human illness.

READ MORE

Pfizer to Organize for Future Growth

News

Pfizer Inc. announced it will organize the company into three businesses.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE